Skip to main content

Genetic Association Information, Affymetrix, Ocimum Biosolutions, BioIT Alliance, DNAStar

Premium
Genetic Association Information Network to Use Affy's SNP 6.0 Arrays
 
The Genetic Association Information Network, a public and private partnership, will use Affymetrix's Genome-Wide Human SNP Array 6.0 in genomic studies of schizophrenia and bipolar disorder, Affy said last week.
 
GAIN is run by the Foundation for the National Institutes of Health, the National Institutes of Health, and Pfizer Global Research and Development.
 
Affy said GAIN scientists will use the Human SNP 6.0 to analyze eight thousand samples from various ethnicities.
 
The company also said the GAIN program will provide information it collects to researchers worldwide through the National Center for Biotechnology Information’s database of Genotype and Phenotype, or dbGap.
 
Financial terms of the agreement were not released.
 

 
Ocimum Biosolutions Joins Microsoft's BioIT Alliance
 
Ocimum Biosolutions last week said that it has joined the BioIT Alliance, a group of biotech and IT companies working with Microsoft to advance biomedical information technology.
 
“We look forward to working with other Alliance partners for coming up with cutting edge integrated informatics solutions for enabling quality R&D,” said Ocimum Biosolutions President Subash Lingareddy.
 
Hyderabad, India-based Ocimum offers a variety of products and services, including microarrays and array-related bioinformatics tools. Other BioIT Alliance members include Applied Biosystems, Thermo Fisher Scientific, Affymetrix, Agilent, and other biomedical informatics, tools, and services companies.
 

 
DNAStar Joins Affymetrix GeneChip Program
 
DNAStar last week said that its ArrayStar microarray data-analysis software has become compatible with Affymetrix’ Gene Chip microarray platform.
 
The company now becomes a member of the Affymetrix GeneChip-compatible Applications Program.
 
DNAStar said the companies will now be able to promote each other’s products through website, training, and promotion channels.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.